BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nielsen KR, Steffensen R, Boegsted M, Baech J, Lundbye-Christensen S, Hetland ML, Krintel SB, Johnsen HE, Nyegaard M, Johansen JS. Promoter polymorphisms in the chitinase 3-like 1 gene influence the serum concentration of YKL-40 in Danish patients with rheumatoid arthritis and in healthy subjects. Arthritis Res Ther 2011;13:R109. [PMID: 21714862 DOI: 10.1186/ar3391] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Kwak SY, Seo IH, Chung I, Kim SA, Lee JO, Lee HJ, Kim SE, Han JA, Kang MJ, Kim SJ, Lim S, Kim KM, Chung JH, Lim E, Hwang JI, Kim HS, Shin MJ. Effect of chitinase-3-like protein 1 on glucose metabolism: In vitro skeletal muscle and human genetic association study. FASEB J 2020;34:13445-60. [PMID: 32816366 DOI: 10.1096/fj.202000925R] [Reference Citation Analysis]
2 Lin YS, Liu YF, Chou YE, Yang SF, Chien MH, Wu CH, Chou CH, Cheng CW, Wang PH. Correlation of chitinase 3-like 1 single nucleotide polymorphisms and haplotypes with uterine cervical cancer in Taiwanese women. PLoS One 2014;9:e104038. [PMID: 25203433 DOI: 10.1371/journal.pone.0104038] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
3 Thomsen SB, Gjesing AP, Rathcke CN, Ekstrøm CT, Eiberg H, Hansen T, Pedersen O, Vestergaard H. Associations of the Inflammatory Marker YKL-40 with Measures of Obesity and Dyslipidaemia in Individuals at High Risk of Type 2 Diabetes. PLoS One 2015;10:e0133672. [PMID: 26197239 DOI: 10.1371/journal.pone.0133672] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
4 Kornblit B, Hellemann D, Munthe-Fog L, Bonde J, Strøm JJ, Madsen HO, Johansen JS, Garred P. Plasma YKL-40 and CHI3L1 in systemic inflammation and sepsis-experience from two prospective cohorts. Immunobiology 2013;218:1227-34. [PMID: 23706599 DOI: 10.1016/j.imbio.2013.04.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
5 Xu T, Zheng X, Wang A, Guo Z, Zhang Y. Association of CHI3L1 gene variants with YKL-40 levels and hypertension incidence: A population-based nested case-control study in China. J Cell Mol Med 2021;25:919-24. [PMID: 33280245 DOI: 10.1111/jcmm.16148] [Reference Citation Analysis]
6 Lee YH, Song GG. YKL-40 Levels in Rheumatoid Arthritis and Their Correlation with Disease Activity: A Meta-analysis. J Rheum Dis 2019;26:257. [DOI: 10.4078/jrd.2019.26.4.257] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
7 Kjaergaard AD, Johansen JS, Bojesen SE, Nordestgaard BG. Observationally and Genetically High YKL-40 and Risk of Venous Thromboembolism in the General Population: Cohort and Mendelian Randomization Studies. Arterioscler Thromb Vasc Biol 2016;36:1030-6. [PMID: 26988593 DOI: 10.1161/ATVBAHA.116.307251] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
8 Thomsen SB, Rathcke CN, Skaaby T, Linneberg A, Vestergaard H. The Association between genetic variations of CHI3L1, levels of the encoded glycoprotein YKL-40 and the lipid profile in a Danish population. PLoS One 2012;7:e47094. [PMID: 23071724 DOI: 10.1371/journal.pone.0047094] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
9 Väänänen T, Vuolteenaho K, Kautiainen H, Nieminen R, Möttönen T, Hannonen P, Korpela M, Kauppi MJ, Laiho K, Kaipiainen-Seppänen O, Luosujärvi R, Uusitalo T, Uutela T, Leirisalo-Repo M, Moilanen E; NEO-RACo Study Group. Glycoprotein YKL-40: A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial. PLoS One 2017;12:e0183294. [PMID: 28841649 DOI: 10.1371/journal.pone.0183294] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
10 Abd El-Fattah AA, Sadik NA, Shaker OG, Kamal AM. Are SMAD7 rs4939827 and CHI3L1 rs4950928 polymorphisms associated with colorectal cancer in Egyptian patients? Tumour Biol 2016;37:9387-97. [PMID: 26779637 DOI: 10.1007/s13277-016-4813-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
11 Abd El-Fattah AA, Sadik NAH, Shaker OG, Mohamed Kamal A. Single Nucleotide Polymorphism in SMAD7 and CHI3L1 and Colorectal Cancer Risk. Mediators Inflamm 2018;2018:9853192. [PMID: 30498395 DOI: 10.1155/2018/9853192] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
12 Tao H, Yang J, Shi K, Huang C, Zhang L, Lv X, Li J. The significance of YKL-40 protein in liver fibrosis. Inflamm Res 2014;63:249-54. [DOI: 10.1007/s00011-013-0698-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
13 Nielsen KR, Rodrigo-domingo M, Steffensen R, Baech J, Bergkvist KS, Oosterhof L, Schmitz A, Bødker JS, Johansen P, Vogel U, Vangsted A, Dybkær K, Bøgsted M, Johnsen HE. Interactions between SNPs affecting inflammatory response genes are associated with multiple myeloma disease risk and survival. Leukemia & Lymphoma 2017;58:2695-704. [DOI: 10.1080/10428194.2017.1306643] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
14 De Lauretis A, Renzoni EA. Molecular Biomarkers in Interstitial Lung Diseases. Mol Diagn Ther 2014;18:505-22. [DOI: 10.1007/s40291-014-0109-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
15 Kjaergaard AD, Nordestgaard BG, Johansen JS, Bojesen SE. Observational and genetic plasma YKL-40 and cancer in 96,099 individuals from the general population. Int J Cancer 2015;137:2696-704. [PMID: 26095694 DOI: 10.1002/ijc.29638] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
16 Majewski S, Tworek D, Szewczyk K, Kiszałkiewicz J, Kurmanowska Z, Brzeziańska-Lasota E, Jerczyńska H, Antczak A, Piotrowski WJ, Górski P. Overexpression of chitotriosidase and YKL-40 in peripheral blood and sputum of healthy smokers and patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2019;14:1611-31. [PMID: 31413557 DOI: 10.2147/COPD.S184097] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
17 Shaker OG, Senousy MA. Association of SNP-SNP Interactions Between RANKL, OPG, CHI3L1, and VDR Genes With Breast Cancer Risk in Egyptian Women. Clin Breast Cancer 2019;19:e220-38. [PMID: 30309792 DOI: 10.1016/j.clbc.2018.09.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
18 Kjaergaard AD, Johansen JS, Bojesen SE, Nordestgaard BG. Role of inflammatory marker YKL-40 in the diagnosis, prognosis and cause of cardiovascular and liver diseases. Crit Rev Clin Lab Sci 2016;53:396-408. [PMID: 27187575 DOI: 10.1080/10408363.2016.1190683] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
19 Deng Y, Li G, Chang D, Su X. YKL-40 as a novel biomarker in cardio-metabolic disorders and inflammatory diseases. Clin Chim Acta 2020;511:40-6. [PMID: 33002471 DOI: 10.1016/j.cca.2020.09.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
20 Cantó E, Reverter F, Morcillo-suárez C, Matesanz F, Fernández O, Izquierdo G, Vandenbroeck K, Rodríguez-antigüedad A, Urcelay E, Arroyo R, Otaegui D, Olascoaga J, Saiz A, Navarro A, Sanchez A, Domínguez C, Caminero A, Horga A, Tintoré M, Montalban X, Comabella M. Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis. Mult Scler 2012;18:983-90. [DOI: 10.1177/1352458511433063] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
21 Nada D, Julien C, Rompré PH, Akoume MY, Gorman KF, Samuels ME, Levy E, Kost J, Li D, Moreau A. Association of Circulating YKL-40 Levels and CHI3L1 Variants with the Risk of Spinal Deformity Progression in Adolescent Idiopathic Scoliosis. Sci Rep 2019;9:5712. [PMID: 30952886 DOI: 10.1038/s41598-019-41191-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
22 Shao R. YKL-40 acts as an angiogenic factor to promote tumor angiogenesis. Front Physiol 2013;4:122. [PMID: 23755018 DOI: 10.3389/fphys.2013.00122] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 6.3] [Reference Citation Analysis]
23 Bonella F, Long X, He X, Ohshimo S, Griese M, Guzman J, Costabel U. Serum YKL-40 is a reliable biomarker for pulmonary alveolar proteinosis: Serum YKL-40 as biomarker for PAP. Respirology 2017;22:1371-8. [DOI: 10.1111/resp.13082] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
24 Kjaergaard AD, Johansen JS, Bojesen SE, Nordestgaard BG. Elevated Plasma YKL-40, Lipids and Lipoproteins, and Ischemic Vascular Disease in the General Population. Stroke 2015;46:329-35. [DOI: 10.1161/strokeaha.114.007657] [Cited by in Crossref: 25] [Cited by in F6Publishing: 8] [Article Influence: 3.6] [Reference Citation Analysis]
25 Low D, Tran HT, Lee IA, Dreux N, Kamba A, Reinecker HC, Darfeuille-Michaud A, Barnich N, Mizoguchi E. Chitin-binding domains of Escherichia coli ChiA mediate interactions with intestinal epithelial cells in mice with colitis. Gastroenterology. 2013;145:602-12.e9. [PMID: 23684751 DOI: 10.1053/j.gastro.2013.05.017] [Cited by in Crossref: 38] [Cited by in F6Publishing: 44] [Article Influence: 4.2] [Reference Citation Analysis]
26 Nielsen KR, Steffensen R, Bendtsen MD, Rodrigo-Domingo M, Baech J, Haunstrup TM, Bergkvist KS, Schmitz A, Boedker JS, Johansen P, Dybkaeær K, Boeøgsted M, Johnsen HE. Inherited Inflammatory Response Genes Are Associated with B-Cell Non-Hodgkin's Lymphoma Risk and Survival. PLoS One 2015;10:e0139329. [PMID: 26448050 DOI: 10.1371/journal.pone.0139329] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
27 Mushtaq S, Ghani E, Azam K, Hussain T. Comparison of chitinase-3-like protein 1, aspartate aminotransferase-to-platelet ratio index, and fibrosis-4 index with shear-wave elastography. Eur J Gastroenterol Hepatol 2019;31:357-62. [PMID: 30431458 DOI: 10.1097/MEG.0000000000001291] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
28 Kjaergaard AD, Bojesen SE, Nordestgaard BG, Johansen JS. YKL-40 and alcoholic liver and pancreas damage and disease in 86,258 individuals from the general population: cohort and mendelian randomization studies. Clin Chem 2014;60:1429-40. [PMID: 25225167 DOI: 10.1373/clinchem.2014.229096] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
29 Tuten A, Kucur M, Imamoglu M, Oncul M, Acikgoz AS, Sofiyeva N, Ozturk Z, Kaya B, Oral E. Serum YKL-40 levels are altered in endometriosis. Gynecol Endocrinol 2014;30:381-4. [PMID: 24533749 DOI: 10.3109/09513590.2014.887671] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
30 Kjaergaard AD, Johansen JS, Nordestgaard BG, Bojesen SE. Genetic variants in CHI3L1 influencing YKL-40 levels: resequencing 900 individuals and genotyping 9000 individuals from the general population. J Med Genet 2013;50:831-7. [PMID: 24062521 DOI: 10.1136/jmedgenet-2013-101908] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]